Presented by Kathryn L. Tucker, JD, Special Advocacy Advisor National Psychedelics Association
Modern era clinical trials show psilocybin-assisted therapy brings “immediate, substantial and sustained” relief from anxiety and depression in patients with advanced cancer. Palliative care providers are eager to add a new palliative care tool to their toolbox to address non-physical suffering. This presentation will briefly review the trials and findings, the prohibited status of psilocybin under current law, and efforts to evolve the law to allow access for therapeutic purposes. Discussion will include Oregon’s pioneering Psilocybin Services Act, the first state law to legalize and regulate this substance, despite its federal status.
More about Ms. Tucker, including publications and presentations